{
 "page": "https://insights.moraph.com/compare/part-2-vs-hipaa",
 "csv": "https://insights.moraph.com/compare/part-2-vs-hipaa.csv",
 "publisher": "Moraph",
 "license": "https://creativecommons.org/licenses/by/4.0/",
 "license_note": "License: CC BY 4.0. Underlying government texts are public domain or under their own terms.",
 "attribution": "Moraph Insights, https://insights.moraph.com/compare/part-2-vs-hipaa",
 "slug": "part-2-vs-hipaa",
 "title": "42 CFR part 2 and HIPAA compared: consent, redisclosure, proceedings, breaches and penalties",
 "sector": "Healthcare",
 "lens": "Regulation & Compliance",
 "in_short": "Substance use disorder records from federally assisted substance use disorder programs still need written patient consent under 42 CFR part 2, but since the 2024 rule a patient can give one consent for all future treatment, payment and health care operations, and covered entities and business associates that receive records for those purposes may redisclose them as HIPAA allows, except for proceedings against the patient. HIPAA itself needs no authorization for those purposes, except for psychotherapy notes and other uses that require one. Part 2 records still may not be used in civil, criminal, administrative or legislative proceedings against the patient without consent or a court order. Part 2 programs now follow HIPAA's breach notification rule (no later than 60 calendar days after discovery), the enforcement provisions of 45 CFR part 160 and a complaint route to the HHS Secretary, and compliance with the 2024 rule was required by February 16, 2026.",
 "method": "Each row compares the eCFR text of 42 CFR part 2 with the eCFR text of HIPAA's rules in 45 CFR parts 160 and 164, both as of 2026-11-12, and uses the 2024 final rule (89 FR 12472, February 16, 2024) for dates and for the accounting-of-disclosures tolling. The eCFR version history shows no change to part 2 after September 17, 2024 and none to 45 CFR 164.528 since 2016, and a Federal Register search on 2026-11-14 found no later part 2 rule. Federal Register full text was read through govinfo.gov. HHS web pages were not used. Statutes (42 U.S.C. 290dd-2 and the HIPAA penalty sections) were not opened. This table explains the rules; it is not legal advice.",
 "published": "2026-11-14",
 "last_reviewed": "2026-11-14",
 "columns": [
  {
   "id": "topic",
   "label": "Question"
  },
  {
   "id": "part2",
   "label": "42 CFR part 2 (as amended in 2024)"
  },
  {
   "id": "hipaa",
   "label": "HIPAA Privacy and Breach Notification Rules"
  }
 ],
 "rows": [
  {
   "id": "rule-text",
   "cells": {
    "topic": {
     "text": "Rule text",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "part2": {
     "text": "42 CFR part 2, Confidentiality of Substance Use Disorder Patient Records, as amended by the final rule of February 16, 2024 (89 FR 12472)",
     "source": "s2",
     "checked": "2026-11-14"
    },
    "hipaa": {
     "text": "45 CFR part 160 (general and enforcement provisions) and part 164 subparts D (breach notification) and E (privacy)",
     "source": "s4",
     "checked": "2026-11-14"
    }
   }
  },
  {
   "id": "who",
   "cells": {
    "topic": {
     "text": "What and who it covers",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "part2": {
     "text": "Records that would identify a patient as having or having had a substance use disorder, obtained by a federally assisted substance use disorder program. Federal assistance includes, for example, Medicare participation, or registration under the Controlled Substances Act to dispense a substance to the extent it is used in substance use disorder treatment. The restrictions also bind people who receive the records from a part 2 program, covered entity, business associate, intermediary or other lawful holder and are told of the redisclosure prohibition",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "hipaa": {
     "text": "Health plans, health care clearinghouses, health care providers that transmit health information electronically in covered transactions, and, where stated, business associates",
     "source": "s4",
     "checked": "2026-11-14"
    }
   }
  },
  {
   "id": "tpo-consent",
   "cells": {
    "topic": {
     "text": "Consent for treatment, payment and health care operations",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "part2": {
     "text": "Written consent required. A patient may give one consent for all future uses and disclosures for treatment, payment and health care operations, which lasts until revoked in writing",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "hipaa": {
     "text": "No authorization needed, except where 45 CFR 164.508 requires one (such as most uses of psychotherapy notes); a covered entity may use or disclose for these purposes and may choose to obtain consent",
     "source": "s3",
     "checked": "2026-11-14"
    }
   }
  },
  {
   "id": "notes",
   "cells": {
    "topic": {
     "text": "Counseling or psychotherapy notes",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "part2": {
     "text": "SUD counseling notes need their own consent, with limited exceptions; that consent can be combined only with another consent for SUD counseling notes, and treatment, payment, enrollment or benefits may not be conditioned on it",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "hipaa": {
     "text": "Psychotherapy notes generally need an authorization, with limited exceptions",
     "source": "s3",
     "checked": "2026-11-14"
    }
   }
  },
  {
   "id": "redisclosure",
   "cells": {
    "topic": {
     "text": "Redisclosure by the recipient",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "part2": {
     "text": "Each disclosure with consent must carry a part 2 notice and a copy or clear explanation of the consent. Covered entities and business associates that receive records for treatment, payment or operations may redisclose under HIPAA, except for proceedings against the patient",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "hipaa": {
     "text": "An authorization must state that information disclosed under it may be subject to redisclosure by the recipient and no longer protected by the Privacy Rule",
     "source": "s3",
     "checked": "2026-11-14"
    }
   }
  },
  {
   "id": "proceedings",
   "cells": {
    "topic": {
     "text": "Use in legal proceedings",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "part2": {
     "text": "Records may not be used to investigate or bring criminal charges against a patient, or in civil, criminal, administrative or legislative proceedings against the patient, without the patient's consent or a court order under 42 CFR 2.64 or 2.65; this applies to anyone who obtains the records",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "hipaa": {
     "text": "A covered entity may disclose in judicial or administrative proceedings in response to a court or tribunal order, or to a subpoena or discovery request with satisfactory assurance of notice to the individual or of a qualified protective order",
     "source": "s3",
     "checked": "2026-11-14"
    }
   }
  },
  {
   "id": "breach",
   "cells": {
    "topic": {
     "text": "Breach notification",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "part2": {
     "text": "HIPAA's breach notification provisions (45 CFR part 160 and part 164 subpart D) apply to part 2 programs for breaches of unsecured records in the same manner as they apply to covered entities",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "hipaa": {
     "text": "Notify affected individuals without unreasonable delay and no later than 60 calendar days after discovery of a breach",
     "source": "s3",
     "checked": "2026-11-14"
    }
   }
  },
  {
   "id": "penalties",
   "cells": {
    "topic": {
     "text": "Penalties",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "part2": {
     "text": "Violations are subject to the penalties in sections 1176 and 1177 of the Social Security Act (42 U.S.C. 1320d-5 and 1320d-6), and 45 CFR part 160 subparts C, D and E apply to noncompliance as for covered entities",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "hipaa": {
     "text": "For violations on or after February 18, 2009, four tiers by culpability: minimums of $100, $1,000, $10,000 and $50,000 per violation, a $50,000 per-violation maximum in the first three tiers, and $1,500,000 a calendar year for identical violations; amounts are adjusted for inflation and published at 45 CFR part 102",
     "source": "s4",
     "checked": "2026-11-14"
    }
   }
  },
  {
   "id": "complaints",
   "cells": {
    "topic": {
     "text": "Complaints",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "part2": {
     "text": "Programs must have a process to receive complaints; anyone may complain to the HHS Secretary in the same manner as under 45 CFR 160.306; no retaliation, and patients cannot be required to waive the right",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "hipaa": {
     "text": "A person who believes a covered entity or business associate is not complying may file a complaint with the Secretary",
     "source": "s4",
     "checked": "2026-11-14"
    }
   }
  },
  {
   "id": "accounting",
   "cells": {
    "topic": {
     "text": "Accounting of disclosures",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "part2": {
     "text": "Disclosures made with consent, for up to three years; for treatment, payment and operations only when made through an electronic health record. The 2024 rule tolls compliance with this section until HIPAA's accounting standard (45 CFR 164.528) is revised (not revised as of 2026-11-14)",
     "source": "s2",
     "checked": "2026-11-14"
    },
    "hipaa": {
     "text": "Disclosures in the six years before the request, excluding among others those for treatment, payment and health care operations and those made under an authorization",
     "source": "s3",
     "checked": "2026-11-14"
    }
   }
  },
  {
   "id": "compliance-date",
   "cells": {
    "topic": {
     "text": "Compliance date",
     "source": "s2",
     "checked": "2026-11-14"
    },
    "part2": {
     "text": "Rule effective April 16, 2024; compliance required by February 16, 2026",
     "source": "s2",
     "checked": "2026-11-14"
    }
   }
  }
 ],
 "sources": [
  {
   "id": "s1",
   "title": "42 CFR part 2, Confidentiality of Substance Use Disorder Patient Records (sections 2.3, 2.4, 2.12, 2.16, 2.25, 2.31 to 2.33, 2.64)",
   "publisher": "Office of the Federal Register (eCFR)",
   "url": "https://www.ecfr.gov/current/title-42/chapter-I/subchapter-A/part-2",
   "checked": "2026-11-14"
  },
  {
   "id": "s2",
   "title": "Confidentiality of Substance Use Disorder (SUD) Patient Records, final rule (89 FR 12472, February 16, 2024)",
   "publisher": "Office of the Federal Register (rule issued by the U.S. Department of Health and Human Services)",
   "url": "https://www.federalregister.gov/documents/2024/02/16/2024-02544/confidentiality-of-substance-use-disorder-sud-patient-records",
   "checked": "2026-11-14"
  },
  {
   "id": "s3",
   "title": "45 CFR part 164 (sections 164.404, 164.506, 164.508, 164.512(e) and 164.528)",
   "publisher": "Office of the Federal Register (eCFR)",
   "url": "https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-C/part-164",
   "checked": "2026-11-14"
  },
  {
   "id": "s4",
   "title": "45 CFR part 160 (sections 160.102, 160.306 and 160.404)",
   "publisher": "Office of the Federal Register (eCFR)",
   "url": "https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-C/part-160",
   "checked": "2026-11-14"
  }
 ],
 "omitted": [
  {
   "where": "compliance-date/hipaa",
   "reason": "No HIPAA rule change with a pending or recent compliance date was compared here; the HIPAA cells use the eCFR text as of 2026-11-12."
  }
 ]
}
